Review By | Apply | May Apply | Neutral | Avoid | Not Rated |
---|---|---|---|---|---|
Count | 0 | 0 | 0 | 0 | 0 |
% | 0 | 0 | 0 | 0 | 0 |
[Dilip Davda] The company operates in a highly competitive and fragmented segment with many players. It has posted steady growth in its top and bottom lines and the management is confident of maintaining the trends. It has plans of expansion via acquisition mode in surrounding regions. Based on its financial performance so far, the issue appears fully priced. Well-informed investors may park funds for medium to long-term rewards. Read detail review...
Aatmaj Healthcare Limited peer comparison with similar listed entities. () (As on March 31, 2022)
Company Name | EPS (Rs) | NAV (per share) (Rs) | P/E (x) | RoNW (%) |
---|---|---|---|---|
EPS Basic | ||||
Aatmaj Healthcare Limited | 9.11 | 60.07 | 6.59 | 60.68 |
Krishna Institute of Medical Sciences Ltd | 35.04 | 172.02 | 43.21 | 20.22 |
Kovai Medical Center and Hospital Ltd | 95.28 | 546.86 | 15.86 | 17.42 |
KMC Speciality Hospitals (India) Limited | 1.45 | 5.26 | 42.59 | 27.64 |
Notes:
Aatmaj Healthcare IPO Reviews, analysis and views by popular members. Read Aatmaj Healthcare Ltd. IPO reviews by retail investors to find recommended ipo to buy.
Review By | Apply | May Apply | Neutral | Avoid |
---|---|---|---|---|
Count | 0 | 0 | 0 | 0 |
% | 0.00 | 0.00 | 0.00 | 0.00 |
Member | Review |
---|---|
No recommendation found. Be the first to post the recommendation. |
Note: